Terms: = Uterine cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Treatment
13 results:
1. Synergistic Cytotoxicity Effect of 5-Fluorouracil and shp2 Inhibitor Demethylincisterol A3 on Cervical cancer Cell.
Liu Y; Fu H; Zuo L
Anticancer Agents Med Chem; 2022; 22(7):1313-1319. PubMed ID: 34238199
[TBL] [Abstract] [Full Text] [Related]
2. Demonstrating the effect of shp2 inhibitor on cervical squamous cell carcinoma from the perspective of ZAP70.
Gong M; Liu P; He T; Zhang M; Li G
Anticancer Drugs; 2021 Jun; 32(5):477-483. PubMed ID: 33661186
[TBL] [Abstract] [Full Text] [Related]
3. shp2 expression is upregulated in cervical cancer, and shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells.
Cao M; Gao D; Zhang N; Duan Y; Wang Y; Mujtaba H; Wang Y
Pathol Res Pract; 2019 Nov; 215(11):152621. PubMed ID: 31564571
[TBL] [Abstract] [Full Text] [Related]
4. Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract] [Full Text] [Related]
5. Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression.
Shao H; Ma L; Jin F; Zhou Y; Tao M; Teng Y
Biochem Biophys Res Commun; 2018 Nov; 506(1):243-250. PubMed ID: 30343889
[TBL] [Abstract] [Full Text] [Related]
6. PIAS3, shp2 and SOCS3 Expression patterns in Cervical cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract] [Full Text] [Related]
7. Gamma tocotrienol targets tyrosine phosphatase shp2 in mammospheres resulting in cell death through RAS/ERK pathway.
Gu W; Prasadam I; Yu M; Zhang F; Ling P; Xiao Y; Yu C
BMC Cancer; 2015 Aug; 15():609. PubMed ID: 26315028
[TBL] [Abstract] [Full Text] [Related]
8. Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas.
Li J; Bonifati S; Hristov G; Marttila T; Valmary-Degano S; Stanzel S; Schnölzer M; Mougin C; Aprahamian M; Grekova SP; Raykov Z; Rommelaere J; Marchini A
EMBO Mol Med; 2013 Oct; 5(10):1537-55. PubMed ID: 24092664
[TBL] [Abstract] [Full Text] [Related]
9. shp-2 phosphatase promotes cervical cancer cell proliferation through inhibiting interferon-β production.
Meng F; Zhao X; Zhang S
J Obstet Gynaecol Res; 2013 Jan; 39(1):272-9. PubMed ID: 22889324
[TBL] [Abstract] [Full Text] [Related]
10. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
Saydmohammed M; Joseph D; Syed V
J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
[TBL] [Abstract] [Full Text] [Related]
11. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
[TBL] [Abstract] [Full Text] [Related]
12. Vanadate regulates the insulin mitogenic effect by modulating shp-2 association with insulin receptor substrate 1 in JAr human choriocarcinoma cells.
Bifulco G; Caruso M; Di Carlo C; Acunzo G; Votino C; Pellicano M; Beguinot F; Nappi C
Gynecol Endocrinol; 2003 Jun; 17(3):239-45. PubMed ID: 12857432
[TBL] [Abstract] [Full Text] [Related]
13. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.
Koizumi M; Uede T; Shijubo N; Kudo R; Hashimoto M; Kikuchi K
Cancer Res; 1988 Nov; 48(22):6565-72. PubMed ID: 3052807
[TBL] [Abstract] [Full Text] [Related]
